349 related articles for article (PubMed ID: 34248971)
1. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.
Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ
Front Immunol; 2021; 12():687254. PubMed ID: 34248971
[TBL] [Abstract][Full Text] [Related]
2. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
[TBL] [Abstract][Full Text] [Related]
3. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
[TBL] [Abstract][Full Text] [Related]
4. Kidney paired donation in the presence of donor-specific antibodies.
Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
[TBL] [Abstract][Full Text] [Related]
5. The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.
Heidt S; Witvliet MD; Haasnoot GW; Claas FH
Transpl Immunol; 2015 Oct; 33(2):51-7. PubMed ID: 26325207
[TBL] [Abstract][Full Text] [Related]
6. A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.
Mumford L; Fuggle SV; Martorell J; Slavcev A; Iniotaki A; Haasnoot GW; Heidt S; Claas FHJ
Transpl Immunol; 2021 Feb; 64():101354. PubMed ID: 33276060
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.
van den Berg-Loonen EM; Billen EV; Voorter CE; van Heurn LW; Claas FH; van Hooff JP; Christiaans MH
Transplantation; 2008 Apr; 85(8):1086-90. PubMed ID: 18431226
[TBL] [Abstract][Full Text] [Related]
8. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
Schinstock CA; Gandhi M; Cheungpasitporn W; Mitema D; Prieto M; Dean P; Cornell L; Cosio F; Stegall M
Transplantation; 2017 Oct; 101(10):2429-2439. PubMed ID: 28009780
[TBL] [Abstract][Full Text] [Related]
9. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
10. How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.
Heidt S; Haasnoot GW; Claas FHJ
Curr Opin Organ Transplant; 2018 Aug; 23(4):493-499. PubMed ID: 29846197
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both.
Doxiadis II; Claas FH
Curr Opin Organ Transplant; 2009 Aug; 14(4):410-3. PubMed ID: 19417658
[TBL] [Abstract][Full Text] [Related]
12. The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients.
Jackson AM
Clin Transpl; 2014; ():131-6. PubMed ID: 26281137
[TBL] [Abstract][Full Text] [Related]
13. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
[TBL] [Abstract][Full Text] [Related]
15. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
[TBL] [Abstract][Full Text] [Related]
16. Highly Sensitized Patients: Miami Transplant Institute Experience.
Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
18. Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.
Baxter-Lowe LA; Cecka M; Kamoun M; Sinacore J; Melcher ML
Am J Transplant; 2014 Jul; 14(7):1592-8. PubMed ID: 24934640
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.
Amrouche L; Aubert O; Suberbielle C; Rabant M; Van Huyen JD; Martinez F; Sberro-Soussan R; Scemla A; Tinel C; Snanoudj R; Zuber J; Cavalcanti R; Timsit MO; Lamhaut L; Anglicheau D; Loupy A; Legendre C
Transplantation; 2017 Oct; 101(10):2440-2448. PubMed ID: 28114171
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
